市場調査レポート

商品コード

1533615

プレシジョンメディシンの市場規模、シェア、成長分析：タイプ別、適応症別、最終用途別、地域別 - 産業予測、2024年～2031年

Precision Medicine Market Size, Share, Growth Analysis, By Type (Inhibitor Drugs, Monoclonal Antibodies), By Indication (Oncology, Infectious Diseases), By End-use (Hospitals and Clinics, Home Care Settings), By Region - Industry Forecast 2024-2031

出版日: 2024年08月09日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のプレシジョンメディシンの市場規模は、2022年に285億米ドルとなり、予測期間（2024年～2031年）のCAGRは11.4%で、2023年の317億5,000万米ドルから、2031年までには753億米ドルに成長する見通しです。

ゲノム研究、バイオテクノロジー、データ分析の進歩により、プレシジョンメディシン市場は大きく成長すると予測されます。がんや心血管疾患などの慢性疾患の有病率が上昇していることが、プレシジョンメディシンが提供する個別化治療計画への需要を促進しています。このアプローチは、同じ病気であっても、遺伝的・環境的要因によって治療に対する反応が異なるという考え方に基づいています。SkyQuestの分析によると、プレシジョンメディシン治療に対する世界の支出は2023年に380億9,000万米ドルに達しました。プレシジョンメディシンは、患者の症状、遺伝情報、環境の影響を考慮して治療戦略を調整します。患者の症状の分子的原因を調査し、標的療法を開発するために、システム生物学やパンオミクスが関与することも多いです。プレシジョンメディシンの利点には、個々のニーズや病気のタイプに合わせてカスタマイズされた、より効果的な治療が含まれ、治療費を削減し、不必要な薬物介入を最小限に抑える可能性があります。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主要な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Illumina, Inc.（US）
Thermo Fisher Scientific Inc.（US）
Novartis AG（Switzerland）
Abbott Laboratories（US）
Agilent Technologies（US）
Almac Group（Northern Ireland）
Amgen Inc.（US）
Astellas Pharma Inc.（Japan）
AstraZeneca PLC（United Kingdom）
Bio-Rad Laboratories, Inc.（US）
Bristol-Myers Squibb Company（US）
Danaher Corporation（US）
F. Hoffmann-La Roche Ltd.（Switzerland）
GE Healthcare（US）
Intomics A/S（Denmark）
Merck & Co., Inc.（US）
Myriad Genetics, Inc.（US）
Pfizer Inc.（US）
Qiagen N.V.（Germany）
Quest Diagnostics（US）

Product Code: SQMIG35B2061

Global Precision Medicine Market size was valued at USD 28.50 billion in 2022 and is poised to grow from USD 31.75 billion in 2023 to USD 75.30 billion by 2031, growing at a CAGR of 11.4% in the forecast period (2024-2031).

The precision medicine market is projected to experience significant growth, driven by advances in genomic research, biotechnology, and data analytics. The rising prevalence of chronic diseases, such as cancer and cardiovascular conditions, is fueling demand for personalized treatment plans that precision medicine provides. This approach is based on the concept that individuals with the same disease may respond differently to treatment based on their unique genetic and environmental factors. Based on SkyQuest's analysis, global spending on precision medicine treatments reached USD 38.09 billion in 2023. Precision medicine takes into account a patient's symptoms, genetic information, and environmental influences to tailor treatment strategies. It often involves system biology and pan-omics to investigate the molecular causes of a patient's condition and develop targeted therapies. The benefits of precision medicine include more effective treatments customized to individual needs and disease types, potentially reducing treatment costs and minimizing unnecessary pharmaceutical interventions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Precision Medicine Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Precision Medicine Software Market Segmental Analysis

The precision medicine market is segmented based on Type, Indication, End-user, and Region. Based on Type, the market is segmented into Inhibitor Drugs, Monoclonal Antibodies, Cell and Gene Therapy, Antiviral and Antiretroviral Drugs, and Others. Based on Indication, the market is segmented into Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others. Based on End-user, the market is segmented into Hospitals & Clinics, and Home Care Settings. Based on Region, the market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East and Africa.

Drivers of the Global Precision Medicine Software Market

Advancements in cancer biologics are a key driver behind the growth of precision medicine in the global market. The development of innovative therapeutic approaches, such as gene therapy for cancer treatment, is also expected to further accelerate market expansion. Precision medicine provides customized solutions tailored to patients' genetic profiles and disease characteristics, offering the potential for better outcomes and fewer side effects compared to traditional treatments.

Restraints in the Global Precision Medicine Software Market

Precision medicine is advancing rapidly, but the rising costs of diagnostics could hinder market growth. The process of diagnosing and treating patients generates a substantial amount of personal data, and associated privacy risks may restrict the market's expansion. Additionally, stringent regulations and standards are posing challenges to the growth of the personalized medicine sector.

Market Trends of the Global Precision Medicine Software Market

A key trend in the precision medicine market is the integration of advanced computer technologies, such as artificial intelligence (AI) and machine learning, into medication management. These technologies help organize extensive health and genetic data, leading to improved insights into disease patterns and treatment effectiveness. AI identifies new health indicators and develops personalized treatment strategies, enhancing research and care quality. This shift is driving innovative approaches and smart strategies in the adoption of precision medicine.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Supply Chain Analysis
Pipeline Analysis
Patent Analysis
Trade Analysis
Customer & Buying Criteria Analysis
Ecosystem of the Market
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Global Precision Medicine Market by Type

Market Overview
Inhibitor drugs
Monoclonal antibodies
Cell and gene therapy
Antiviral and antiretroviral drugs
Other therapeutic products

Global Precision Medicine Market by Indication

Market Overview
Oncology
Rare diseases
Infectious diseases
Hematological disorders
Other indications

Global Precision Medicine Market by End User

Market Overview
Hospitals and Clinics
Home Care Settings

Global Precision Medicine Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group (Northern Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca PLC (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intomics A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

プレシジョンメディシンの市場規模、シェア、成長分析：タイプ別、適応症別、最終用途別、地域別 - 産業予測、2024年～2031年

Precision Medicine Market Size, Share, Growth Analysis, By Type (Inhibitor Drugs, Monoclonal Antibodies), By Indication (Oncology, Infectious Diseases), By End-use (Hospitals and Clinics, Home Care Settings), By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主要な市場の考察

プレシジョンメディシン市場：タイプ別

プレシジョンメディシン市場：適応症別

プレシジョンメディシン市場：エンドユーザー別

プレシジョンメディシン市場規模：地域別